BSA and ABCB1 polymorphism affect the pharmacokinetics of sunitinib and its active metabolite in Asian mRCC patients receiving an attenuated sunitinib dosing regimen.
Cancer chemotherapy and pharmacology 2016 Aug .
Chae Jung-Woo, Teo Yi Ling, Ho Han Kiat, Lee Jaeyeon, Back Hyun-Moon, Yun Hwi-Yeol, Karlsson Mats O, Kwon Kwang-Il, Chan Alexand
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 29, 2019
- Content source: